MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 228 filers reported holding MIRATI THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,614,366 | +28.2% | 2,745,968 | +6.4% | 0.01% | +40.0% |
| Q2 2023 | $93,278,230 | +8.6% | 2,581,739 | +11.8% | 0.01% | 0.0% |
| Q1 2023 | $85,879,005 | -62.8% | 2,309,820 | -54.6% | 0.01% | -28.6% |
| Q4 2022 | $230,680,098 | +110.2% | 5,091,152 | +224.0% | 0.01% | 0.0% |
| Q3 2022 | $109,756,000 | -12.9% | 1,571,539 | -16.3% | 0.01% | -12.5% |
| Q2 2022 | $125,977,000 | +7.6% | 1,876,615 | +31.8% | 0.01% | +33.3% |
| Q1 2022 | $117,046,000 | -22.9% | 1,423,565 | +37.5% | 0.01% | -14.3% |
| Q4 2021 | $151,892,000 | -6.2% | 1,035,464 | +13.1% | 0.01% | -22.2% |
| Q3 2021 | $161,981,000 | +19.4% | 915,613 | +9.0% | 0.01% | +28.6% |
| Q2 2021 | $135,633,000 | -25.2% | 839,678 | -20.6% | 0.01% | -30.0% |
| Q1 2021 | $181,265,000 | -23.3% | 1,058,171 | -1.7% | 0.01% | -28.6% |
| Q4 2020 | $236,340,000 | +30.8% | 1,076,033 | -1.1% | 0.01% | +16.7% |
| Q3 2020 | $180,636,000 | +28.0% | 1,087,840 | -12.0% | 0.01% | +20.0% |
| Q2 2020 | $141,137,000 | +44.4% | 1,236,198 | -2.8% | 0.01% | +11.1% |
| Q1 2020 | $97,763,000 | -38.6% | 1,271,796 | +3.0% | 0.01% | -18.2% |
| Q4 2019 | $159,111,000 | +54.3% | 1,234,762 | -6.7% | 0.01% | +37.5% |
| Q3 2019 | $103,096,000 | -12.4% | 1,323,270 | +15.9% | 0.01% | -11.1% |
| Q2 2019 | $117,639,000 | +13.7% | 1,142,123 | -19.1% | 0.01% | +12.5% |
| Q1 2019 | $103,502,000 | +59.3% | 1,412,039 | -7.8% | 0.01% | +33.3% |
| Q4 2018 | $64,968,000 | -1.7% | 1,531,549 | +9.1% | 0.01% | +20.0% |
| Q3 2018 | $66,107,000 | +37.4% | 1,403,516 | +43.8% | 0.01% | +25.0% |
| Q2 2018 | $48,109,000 | +124.6% | 975,822 | +39.9% | 0.00% | +100.0% |
| Q1 2018 | $21,420,000 | +64.3% | 697,707 | -2.3% | 0.00% | +100.0% |
| Q4 2017 | $13,036,000 | +3561.8% | 714,281 | +2248.3% | 0.00% | – |
| Q3 2017 | $356,000 | +626.5% | 30,417 | +125.0% | 0.00% | – |
| Q2 2017 | $49,000 | -95.6% | 13,517 | -93.6% | 0.00% | – |
| Q1 2017 | $1,107,000 | +22.3% | 212,538 | +11.8% | 0.00% | – |
| Q4 2016 | $905,000 | -19.2% | 190,179 | +12.4% | 0.00% | – |
| Q3 2016 | $1,120,000 | +22.1% | 169,234 | +0.7% | 0.00% | – |
| Q2 2016 | $917,000 | -87.8% | 168,077 | -52.0% | 0.00% | -100.0% |
| Q1 2016 | $7,498,000 | -35.8% | 350,525 | -5.2% | 0.00% | 0.0% |
| Q4 2015 | $11,678,000 | +137.9% | 369,596 | +159.1% | 0.00% | 0.0% |
| Q3 2015 | $4,909,000 | +32.5% | 142,639 | +21.1% | 0.00% | – |
| Q2 2015 | $3,705,000 | +40.7% | 117,813 | +31.2% | 0.00% | – |
| Q1 2015 | $2,633,000 | +112.2% | 89,796 | +33.9% | 0.00% | – |
| Q4 2014 | $1,241,000 | +10.9% | 67,070 | +4.8% | 0.00% | – |
| Q3 2014 | $1,119,000 | -3.1% | 63,980 | +10.8% | 0.00% | – |
| Q2 2014 | $1,155,000 | – | 57,743 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |